Jaguar Health, Inc. — Form 8-K
Filed September 28, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 78/100
What the filing says
On September 25, 2026, Jaguar Health agreed to exchange a partitioned portion of a secured promissory note originally issued to Streeterville Capital, LLC (a Utah LLC) on January 19, 2021, for an unspecified number of freely tradable common shares. The specific dollar amount of the partitioned note and share count are redacted in the filing (shown as blanks). The original note's remaining balance is reduced by the partitioned amount; no other consideration changes hands. The exchange is structured under Securities Act Section 3(a)(9) to permit unrestricted resale under Rule 144, with holding period tacking to January 19, 2021.
Why this rating
Dollar amount and share count are blanked, preventing full materiality assessment. However, conversion of debt to equity at a $3.8M market-cap company is structurally significant—it reduces leverage and dilutes existing shareholders. The 9.99% ownership cap and redemption of prior debt merit concern, but lack of concrete figures limits scoring.
Price action (we called it neutral)
before filing · preread $7.09 | at our read pending | +10 min pending | +30 min pending | +1 hr pending | +4 hrs pending |
Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →
See more from September 28, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.